Cravath represented Evolent Health, Inc. in connection with its $175 million registered common stock offering. Evolent Health partners with leading provider organizations to achieve superior clinical and financial results in value-based care. The shares were listed on the New York Stock Exchange. The transaction closed on August 14, 2017.
The Cravath team included partner William V. Fogg, practice area attorney Elizabeth A. Morgan and associates Ryan M. Farha and Cole‑Gabriel DuMond.